Location History:
- Dallas, TX (US) (2021)
- Coppell, TX (US) (2023)
Company Filing History:
Years Active: 2021-2024
Title: Innovations by Inventor Mingli Chen
Introduction
Mingli Chen is a notable inventor based in Dallas, TX (US). He has made significant contributions to the field of stereotactic radiotherapy, holding a total of 3 patents. His work focuses on improving treatment planning systems and verification methods in clinical settings.
Latest Patents
One of his latest patents is titled "Independent stereotactic radiotherapy dose calculation and treatment plan verification." This patent describes a treatment planning system designed for use in stereotactic radiotherapy. The system generates treatment plans and verifies existing ones, ensuring accuracy in clinical applications. The method involves receiving a treatment plan, generating a second treatment plan using a modified Monte Carlo method, and identifying discrepancies between the two plans.
Another significant patent is "Dose volume histogram and dose distribution based autoplanning." This invention outlines a method and system for creating a voxel-based quadratic penalty model for automatic intensity-modulated radiation therapy (IMRT) treatment planning. The computing system dynamically updates threshold values based on dose value changes, allowing for continuous improvement in treatment planning.
Career Highlights
Mingli Chen is affiliated with the University of Texas System, where he applies his expertise in radiotherapy and treatment planning. His innovative approaches have the potential to enhance patient outcomes in cancer treatment.
Collaborations
Mingli has collaborated with esteemed colleagues such as Weiguo Lu and Steve B Jiang, contributing to advancements in the field of radiotherapy.
Conclusion
Mingli Chen's contributions to stereotactic radiotherapy through his patents and work at the University of Texas System highlight his commitment to improving cancer treatment methodologies. His innovative solutions are paving the way for more effective and accurate treatment planning systems.